Thrombosis risk of drug eluting
Selected Abstract
Thrombosis risk of drug-eluting stents remains for 3 years.(News)
BARCELONA -- The rate of late stent thrombosis remained steady at 0.6% per year from 30 days through 3 years after drug-eluting stent implantation in a large cohort study, Dr. Peter Wenaweser reported at the joint congress of the European Society of Cardiology and the World Heart Federation. The ... November 1, 2006; Internal Medicine News
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Thrombosis risk of drug-eluting stents remains for 3 years.(News)
2.
SurModics Announces First Human Use of Finale(TM) Prohealing Coating Technology on Nexeon MedSystems' PROTEX(TM) Coronary Stent System.
3.
Nexeon MedSystems, Inc., Announces Enrollment of First Patient in Feasibility Trial for Novel Prohealing Stent System.
|
